ScholarWorks@Korea University: Rha, Seung Woon

Detailed Information

Rha, Seung Woon (나승운)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 구3020
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:41||Myocardial infarction:32||Percutaneous coronary intervention:26||drugeluting stent:16||coronary artery disease:15||Acute myocardial infarction:14||myocardial infarction:12||Prognosis:11||Coronary artery disease:11||Drugeluting stent:11||Coronary artery spasm:10||Drugeluting stents:9||chronic total occlusion:9||Diabetes mellitus:9||acute myocardial infarction:9||drugeluting stents:8||atrial fibrillation:8||hypertension:8||coronary artery spasm:8||acute coronary syndrome:8||stents:8||acetylcholine:7||outcomes:7||Metabolic syndrome:6||angioplasty:6||Atrial fibrillation:6||Acetylcholine:6||Angioplasty:6||diabetes mellitus:6||peripheral artery disease:6||Peripheral artery disease:5||catheter ablation:5||Rosuvastatin:5||coronary angiography:4||computed tomography:4||cilostazol:4||critical limb ischemia:4||Cilostazol:4||Clinical outcomes:4||Myocardial Infarction:4||Statins:3||clopidogrel:3||Bifurcation:3||Atorvastatin:3||Acute coronary syndrome:3||Chronic total occlusion:3||Myocardial bridge:3||Acetylcholine provocation test:3||vasospastic angina:3||Hypertension:3||endothelial dysfunction:3||lipoprotein(a):3||Hemorrhage:3||dyslipidemia:3||Antiplatelet agents:3||angina:3||Coronary angiography:3||restenosis:3||Elderly:3||blood pressure:3||diabetes:3||Percutaneous transluminal angioplasty:3||clinical outcomes:3||radial artery:3||nonSTsegment elevation myocardial infarction:3||left atrium:3||Inflammation:3||STEMI:3||Mortality:3||Sirolimuseluting stents:3||treatment outcome:3||Aorta:2||Blood pressure:2||inflammation:2||zotarolimuseluting stents:2||Echocardiography:2||Prognosis.:2||Cardiovascular outcome:2||coronary artery bypass grafting:2||STelevation myocardial infarction:2||coronary disease:2||Angiotensinconvertingenzyme inhibitors:2||uric acid:2||Angiotensin:2||rosuvastatin:2||telmisartan:2||Obesity:2||Atherosclerosis:2||clinical outcome:2||Platelet function test:2||DrugEluting Stents:2||Calcium channel blocker:2||Hypercholesterolemia:2||outcome:2||medical therapy:2||angiotensin receptor blocker:2||Clopidogrel:2||Creactive protein:2||sirolimus:2||Paclitaxeleluting stents:2||insulin resistance:2||triple combination:2||revascularization:2||Cholesterol:2||stroke:2||Prasugrel:2||bifurcation lesions:2||DES:2||Drugcoated balloon:2||Heparin:2||percutaneous transluminal angioplasty:2||Intravascular ultrasound:2||rotational atherectomy:2||coronary artery bypass:2||coronary occlusion:2||Percutaneous Coronary Intervention:2||Age of onset:2||newonset diabetes mellitus:2||statin:2||Machine learning:2||vasospasm:2||Vasospastic angina:2||Angina:2||calcification:2||Coronary bifurcation:2||coronary bifurcation lesion:2||Neutrophil/lymphocyte ratio:2||drugeluting stent(s):2||Angiotensin converting enzyme inhibitor:2||Ezetimibe:2||amlodipine:2||multivessel disease:2||air pollution:2||risk factors:2||major adverse cardiac events:2||Complications:2||Uric acid:2||Insulin resistance:2||Cardiovascular diseases:2||paclitaxel:2||stable angina:2||Critical limb ischemia:2||lowdensity lipoprotein cholesterol:2||thrombolysis in myocardial infarction flow:2||hypercholesterolemia:2||blood pressure control:2||bifurcation lesion:2||nitrate:2||Anticoagulation:1||sleep quality:1||meloxicam:1||safety:1||endovascular therapy:1||registries:1||Cardiogenic shock:1||nonSTEMI:1||Diagnosis:1||risk assessment:1||coronary bifurcation:1||intracoronary acetylcholine provocation test:1||Transfemoral intervention:1||Access site:1||Biolimuseluting stent:1||carvedilol:1||Angiotensin II receptor blocker:1||stent boost:1||Left main coronary artery:1||HydroxymethylglutarylCoA reductase inhibitors:1||atrial function:1||Thrombectomy:1||Cigarette smoking:1||Noncompliant balloon:1||angiotensin converting enzyme inhibitor:1||myocardial fractional flow reserve:1||unstable plaque:1||bifurcation:1||preoperative care/methods:1||recurrence:1||peripheral transluminal angioplasty:1||stenosis:1||Hyperuricemia:1||stent technique:1||Platelet function:1||Acute Coronary Syndrome:1||DEATH:1||central blood pressure:1||ASSOCIATION:1||OCCLUSION:1||Kidney:1||Achinduced coronary vasospasm:1||Psychiatric status rating scales:1||coronary artery disease/prevention & control/therapy:1||prior cerebrovascular disease:1||peripheral arterial disease:1||Drug eluting stent:1||Congenital:1||Coronary vessels:1||multidetector computed tomography:1||threedimensional multidetector CT:1||clinical:1||Arterial inflammation:1||ACS:1||Age ≥80 years:1||Asian population:1||Betablockers:1||Superficial femoral artery:1||IL17:1||1stent:1||Complex lesion:1||handgrip:1||clinically driven target lesion revascularization:1||surgical conversion:1||odds ratio:1||platelet aggregation inhibitors:1||Antihypertensive:1||ultrathinstrut drugeluting stent:1||quantitative coronary analysis:1||Newonset diabetes mellitus:1||hyperlipidemia:1||statin responsiveness:1||prediction:1||anemia:1||type:1||NonSTSegment elevation myocardial infarction:1||coronary circulation:1||prediabetes:1||hyperuricaemia:1||Clinical followup:1||nonselective ssblockers:1||bisoprolol:1||CTO:1||BVS:1||OCT:1||Drug eluting stents:1||mortality:1||statins:1||Vasomotion type:1||Endovascular procedures:1||Side branch:1||smoking:1||dual antiplatelet therapy:1||Metabolic cardiovascular syndrome:1||Radial artery:1||arterial inflammation:1||Pericardium:1||coronary:1||PTA:1||left main:1||body mass index:1||StentBoost:1||Low density lipoproteincholesterol:1||Coronary artery vasospasm:1||Imaging:1||cardiovascular disease:1||PRIMARY ANGIOPLASTY:1||PROPENSITY SCORE:1||Celecoxib:1||Hydroxy3methylglutarylCoA reductase inhibitors:1||Vasoconstriction:1||Acute nonSTsegment elevation myocardial infarction:1||Aortic calcification:1||Thrombosis:1||Coronary Artery Disease:1||PRASUGREL:1||hyperlipidemias/prevention & control:1||arteriosclerosis/blood:1||biological markers/blood:1||Coronary anomaly:1||Baremetal stent:1||platelets:1||SES:1||RAS inhibitor:1||Nitinol:1||Self expandable metallic stent:1||Vascular patency:1||Air pollution:1||ticagrelor:1||left:1||Selfexpanding nitinol stents:1||Diastolic dysfunction:1||variant angina pectoris:1||age:1||blockers:1||provisional onestent:1||elderly:1||realworld:1||Nitrate:1||prevalence:1||target blood pressure:1||Clinically driven target lesion revascularization:1||Metformin (MET):1||type 2 diabetes mellitus (type 2 DM):1||heart failure:1||optical coherence tomography:1||nonsteroidal antiinflammatory drugs:1||Angiotensin II type 1 receptor blocker:1||chest pain:1||Intermittent claudication:1||Ventricular tachycardia:1||Bifurcation lesions:1||Alcohol:1||selective ss 1blockers:1||STsegment myocardial infarction:1||Paclitaxeleluting stent:1||obesity:1||Lipids:1||clinical followup:1||Ezetimibe simvastatin combination:1||Coronary bifurcation lesion:1||ultrasonography:1||plaque:1||diabetic:1||Drugcoated stents:1||Chest pain:1||Atrial septum:1||Coronary occlusion:1||True bifurcation lesion:1||atrial function, left/physiology:1||longterm outcome:1||Major clinical outcomes:1||atherectomy:1||Linear ablation:1||body composition:1||Radial Artery:1||index of microvascular resistance:1||Shock:1||VIRTUAL HISTOLOGY:1||TISSUE CHARACTERIZATION:1||pulse wave analysis:1||Cardiovascular risk factor:1||small:1||metabolic syndrome:1||Statin:1||Hepatotoxicity:1||Cardiac CT:1||CLOPIDOGREL:1||cytokines:1||epicardial adipose tissue:1||inflammatory:1||Left atrial function:1||Antilipemic agents/therapeutic use:1||Noncardiac surgery:1||Zotarolimuseluting stents:1||adjunctive balloon:1||fibroelastosis:1||noncontact mapping:1||Preserved LV systolic function:1||Amygdalar activity:1||Stent oversizing:1||Histomorphometry:1||HMGB1:1||highrisk:1||patency:1||Asian:1||Angiotensin II type 1 receptor blockers:1||Deescalation:1||sulfonylureas (SU):1||Femoropopliteal artery disease:1||impaired fasting glucose:1||outcome assessment:1||Long coronary lesion:1||Time factors:1||multiple vessel disease:1||randomized controlled trial:1||big data:1||Diabetes:1||Focal spasm:1||hydrochlorothiazide:1||HMGCoA reductase inhibitor:1||epicardial fat:1||Heart rate variability:1||rotablator:1||complex coronary lesions:1||Heart atria:1||Registries:1||heart atria/pathology/ultrasonography:1||Metaanalysis:1||Left main bifurcation:1||Lipoproteins:1||Smoking:1||aortic stenosis:1||side branch:1||Angina pectoris, variant:1||Angiography:1||PERCUTANEOUS CORONARY INTERVENTION:1||dense lowdensity lipoprotein:1||SURVIVAL:1||Alanine transaminase:1||young patients:1||Aged:1||Computed tomography:1||Thrombus aspiration:1||coronary restenosis:1||Enoxaparin:1||Unfractionated heparin:1||remodeling:1||Mean platelet volume:1||Blood Platelets:1||paclitaxeleluting stent:1||sirolimuseluting stent:1||brachytherapy:1||Graft stent:1||visceral artery aneurysms:1||심근경색증:1||pharmacology:1||NSTEACS:1||Health effect:1||Gender difference:1||Stroke:1||Coronary Angiography:1||nitrates:1||interaction term of gender with age:1||ischemia:1||abdominal aortic aneurysm:1||sleep:1||drugeluting:1||acute myocardial infarction (AMI):1||highsensitivity Creactive protein to highdensity lipoprotein cholesterol ratio:1||sleep disorders:1||antithrombotic therapy:1||cardiorespiratory fitness:1||chronic coronary total occlusion:1||intravascular ultrasound:1||Emergency medical services:1||disease progression:1||risk factor:1||Vasospasm:1||Ventricular fibrillation:1||femoral artery:1||Disease burden:1||Hemoglobin A1c:1||ezetimibe:1||biodegradable polymer:1||Coronary artery stenosis:1||coronary calcification:1||coronary vasospasm:1||Transradial coronary angiography:1||Cardiac autonomic dysfunction:1||Stenosis:1||Clinical outcome:1||fibrinolysis:1||Biodegradable implants:1||kissing ballooning:1||ultrasonography, interventional:1||Marker:1||Atrial mass:1||Treatment outcome:1||Catheter ablation:1||Myocardial injury:1||extracellular fluid:1||coronary microvascular function:1||Aortic coarctation:1||RADIOFREQUENCY DATAANALYSIS:1||MECHANICAL REPERFUSION:1||everolimuseluting stents:1||Plaque:1||Hepatic steatosis:1||Pitavastatin:1||Percutaneous transluminal coronary angioplasty:1||paclitaxeleluting stents:1||endothelial function:1||Coronary artery:1||Vascular endothelium:1||Coronary disease:1||Risk factors:1||lipoproteins, LDL/blood/chemistry:1||aorta:1||Single coronary artery:1||Diabetic foot:1||coronary flow:1||BMS:1||endocardium:1||AMI:1||18FFDGPET/CT:1||Particulate matter:1||retrospective studies:1||Rivaroxaban:1||Buerger's disease:1||ADAM10:1||zotarolimus:1||Chronic Renal Insufficiency:1||vasodilator agents:1||Treatment adherence and compliance:1||Motivational interviewing:1||stable:1||dysglycemia:1||atherosclerotic cardiovascular disease:1||femoropopliteal artery:1||6minute walk test:1||type IIIa endoleak:1||Medication therapy:1||sex difference:1||24&#8208:1||hour Holter study:1||pitavastatin:1||survival:1||Endovascular therapy:1||Preprocedural medication:1||machine learning:1||acetylcholine provocation test:1||Peripheral arterial disease:1||left ventricular hypertrophy:1||Single vessel spasm:1||collateral circulation:1||left atrial function:1||particular matter:1||Longterm clinical outcome:1||The elderly patients:1||Atrial remodeling:1||Everolimus:1||cardiac volume:1||prognosis:1||procedurerelated complications:1||Complex fractionated atrial electrograms:1||Treatment:1||Arteriovenous fistula:1||THROMBUS ASPIRATION:1||ANGINAPECTORIS:1||UNSTABLE ANGINA:1||Safety:1||Acetylcholine dose:1||Highsensitivity Creactive protein:1||COLLATERAL BLOODFLOW:1||Aspirin:1||Function:1||sirolimuseluting stents:1||Atrial septal aneurysm:1||thrombosis:1||Angina pectoris:1||bilateral coronary artery fistula:1||superior mesenteric artery aneurysms:1||drug eluting stent:1||예후.:1||cardiovascular events:1||antiplatelet therapy:1||ventricular function:1||coronary artery stenosis:1||Korea:1||Platelet aggregation inhibitors:1||Primary prevention:1||Heart failure with midrange ejection fraction:1||Predictors:1||coronary heart disease:1||(V)over doto(2max):1||incraft stent graft:1||femoropopliteal artery disease:1||stent:1||Chronic limbthreatening ischemia:1||reperfusion:1||dipeptidyl peptidase4 inhibitors (DPP4i):1||nonSTsegmentelevation myocardial infarction:1||Antiplatelet therapy:1||validation studies:1||Spot stenting:1||Sex:1||Acute limb ischemia:1||renal insufficiency:1||Combination therapy:1||clinical events:1||arterial occlusive diseases:1||Multivessel:1||Transradial intervention:1||ST elevation myocardial infarction:1||Vascular complications:1||calcium channel blocker:1||Diltiazem:1||Transradial coronary intervention:1||reninangiotensin system:1||coronary stenosis:1||PET/CT:1||Medina classification:1||Atrial fibrillation/physiopathology:1||tomography, Xray computed/methods:1||female gender:1||dissection:1||betablocker:1||blood sugar control:1||echocardiography:1||Ablation time:1||Occulusion:1||Stents:1||VULNERABLE PLAQUE:1||Asia:1||Creatine kinase:1||ARTERY:1||BIAS:1||THERAPY:1||Stent thrombosis:1||Left atrium:1||Endothelium:1||Coronary calcification:1||multivessel coronary artery spasm:1||Valsartan:1||platelet reactivity:1||lipids:1||aging:1||Coronary rupture:1||communication between two fistulas:1||hand grip strength:1||periprocedural myocardial infarction:1||Coronary occlusion/therapy:1||Ventricular ejection fraction:1||predictor:1||Systolic dysfunction:1||Calcium dobesilate:1||ContrastInduced Acute Kidney Injury:1||gender differences:1||Lifestyle factors:1||vasodilator:1||&#946:1||elective two stent:1||nonleft main bifurcation:1||2stent:1||Bifurcation lesion:1||exercise capacity:1||drugcoated balloons:1||endovascular aneurysm repair:1||followup:1||recovery of function:1||N:1||drugcoated balloon:1||endovascular:1||Pretest probability:1||long lesion: percutaneous coronary intervention:1||Geriatric medicine:1||Amlodipine:1||Candesartan Cilexetil:1||singlepill combination:1||cardiopulmonary coupling analysis:1||celecoxib:1||Cardiac death:1||everolimuseluting stent:1||coronary artery dissection:1||Type 2 diabetes mellitus:1||Angiotensin II receptor blockers:1||Primary percutaneous coronary intervention:1||Quality of life:1||singepill combination:1||Zotarolimuseluting stent:1||Restenosis:1||sex differences:1||air pollutant:1||Aneurysm:1||Dissection:1||Body size phenotype:1||Bleeding:1||chronic total occlusions:1||triple antiplatelet therapy:1||Gastroesophageal reflux:1||predictive value of tests:1||ROC curve:1||ergonovine:1||amputation:1||medina 0,0,1 lesion:1||Everolimuseluting stents:1||myocardial fibrosis:1||aspirin:1||Coronary vessel anomalies:1||abdominal:1||threedimensional:1||INTRAVASCULAR ULTRASOUND:1||augmentation index:1||Fenofibrate:1||smoker's paradox:1||Primary PCI:1||Cryptogenic stroke:1||Metabolic Syndrome:1||Depression:1||particle size:1||cholesterol, LDL/analysis/blood/classification/drug effects:1||pulse wave velocity:1||Drug delivery:1||Large coronary artery:1||ZES:1||recanalization:1||발생 연령:1||arterial stiffness:1||Haematopoietic activity:1||Iliac artery:1||Body mass index:1||Asian dust:1||percutaneous coronary intervention/adverse effects/mortality:1||Outcome:1||coronary bifurcation stenting:1||Chronic outward force:1||Heart failure:1||Diabetes Mellitus:1||Adrenergic betaantagonists:1||cerebral infarction:1||electrocardiography:1||hyperuricemia:1||HTN:1||Angiotensin receptor blocker:1||Newly diagnosed diabetes:1||observational study:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE